A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy

A Rare BRAF Fusion in Advanced Rectal Cancer Treated with Anti-Epidermal Growth Factor Receptor Therapy

Recently, v-raf murine sarcoma viral oncogene homologue B (BRAF) fusions have been identified in multiple cancer types using comprehensive genomic profiling (CGP) assays. BRAF fusions are extremely rare, occurring in <0.5% of patients with metastatic colorectal cancer (mCRC). Until now, the...

Full description

Bibliographic Details
Main Authors: Hiroko Hasegawa, Masaaki Miyo, Kiyoshi Mori, Masayuki Mano, Hisashi Ishida, Eiji Mita
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Case Reports in Oncology
Subjects:
advanced rectal cancer
comprehensive genomic profiling
braf fusion
anti-epidermal growth factor receptor therapy
Online Access:https://www.karger.com/Article/FullText/517007

Similar Items

Similar Items